Reversible Foetal Cerebral Ventriculomegaly and Cardiomyopathy under Chemotherapy for Maternal AML

Publisher： Karger

E-ISSN： 2296-5262|32|1-2|40-43

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.1-2, 2009-01, pp. : 40-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Foetal programming by maternal thyroid disease

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 751-758

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversible cerebral vasoconstriction syndrome

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 6, 2015-06 ,pp. : 599-608

John Wiley & Sons Inc

Access to resources Recommend Favorite

Listeria monocytogenes: Maternal-foetal infections in Denmark 1994-2005

By Smith Birgitte   Kemp Michael   Ethelberg Steen   Schiellerup Peter   Bruun Brita   Gerner-Smidt Peter   Christensen Jens  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 1, 2009-01 ,pp. : 21-25

Informa Healthcare

Access to resources Recommend Favorite

Reversible dilated cardiomyopathy associated with amphotericin B therapy

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 333-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in foetal liver T2* measurements by MRI in response to maternal oxygen breathing: application to diagnosing foetal growth restriction

By Morris David M     McVicar Alexandra     Haggarty Paul   Gilbert Fiona J   Abramovich David R   Smith Norman   Redpath Thomas W  

Physiological Measurement, Vol. 31, Iss. 9, 2010-09 ,pp. : 1137-1146

IOP Publishing

Access to resources Recommend Favorite